John W. Elling

Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service.

Bioreason, Inc. was engaged in developing enterprise software. The company was headquartered in Santa Fe, NM.

Cytoprint, Inc. develops proprietary image classification technology for fluorescence cellular microscopy. Its technology focuses on discovery assays for important biological processes and on linking biological processes to gene and protein function. The company was founded by John W. Elling and Christopher B. Shumate in 2001 and is headquartered in Santa Fe, NM.

Los Alamos National Laboratory operates as a multidisciplinary institution. It offers services in science, engineering, earth science, chemistry, mathematics, physics, and space science. The company was founded in 1943 and is headquartered in Los Alamos, NM.

Acoustic Cytometry Systems, Inc. manufactures cell-testing devices. It commercializes single molecule sensitivity flow cytometers that enable a new generation of proprietary applications in life science research, clinical diagnostics, and industry. The company's products are used for blood exam and medical research. Acoustic Cytometry Systems was founded by John W. Elling in 2006 and is headquartered in Los Alamos, NM

IG Assets products and services are based on ERGO, its web-based genome analysis platform. ERGO integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO provides better and faster identification of gene function across all organisms. Its scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas.

Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM.

xF Technologies, Inc. engages as a technology development company which produces non-toxic specialty chemicals. Its chemical applications include cleaning and processing solvents, plasticizers, coalescents , and personal care. The company was founded by Jacob Berman and Aviad Cahana in January 2007 and is headquartered in Moriarty, NM.

Mitotech LLC develops medical nanotechnology solutions. The firm's pipeline has a number of drug candidates based on mitochondria-addressed antioxidant. Its specialties include nanobiotechnology, drug development, research and development in biology and medicine. The company was founded by Maxim Skulachev and John W. Elling in 2009 and is headquartered in Moscow, Russia.